Neurofibromatosishttps://en.wikipedia.org/wiki/Neurofibromatosis_type_I
Neurofibromatosis is a complex multisystem disorder caused by mutations in the neurofibromin gene. It leads to tumors along the nervous system that can develop anywhere on the body. Neurofibromatosis is one of the most common genetic conditions and follows an autosomal dominant inheritance pattern.

Common manifestations include brown‑red spots on the iris known as Lisch nodules, as well as neurofibromas. Additional features may include scoliosis (curvature of the spine), learning difficulties, visual problems, intellectual disability, multiple café au lait spots, and epilepsy.

There is currently no specific treatment available.

☆ In the 2022 Stiftung Warentest results from Germany, consumer satisfaction with ModelDerm was only slightly lower than with paid telemedicine consultations.
  • Cafe au lait macule seen in Neurofibromatosis type 1 (NF-1)
  • Multiple Neurofibromas (Von Recklinghausen disease)
  • Neurofibroma
  • Multiple small neurofibromas.
  • NF-1 ― Elderly patient's back.
  • Typical manifestation of NF-1. A number of neurofibromas are observed with speckled pigmentation.
  • Patient with facial angiofibroma caused by tuberous sclerosis
References Neurofibromatosis 29083784 
NIH
Neurofibromatosis is a neurocutaneous disorder characterized by tumors in the nervous system and skin. Neurofibromatosis types 1 and 2 are the most common and are distinct entities. Neurofibromatosis type 1, or von Recklinghausen disease, is an autosomal dominant disease. Neurofibromatosis type 1 presents with neurofibromas, cafe-au-lait macules, freckling, and optic gliomas. It is a clinical diagnosis. Neurofibromatosis type 2 (NF2) is a disease characterized by bilateral vestibular schwannomas (VS) and meningiomas. It has an autosomal dominant inheritance pattern. Treatment for neurofibromatosis types 1 and 2 is clinical monitoring and medical intervention when appropriate.